Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

BMS researchers identify novel VEGFR2 and FGFR1 inhibitors

March 5, 2004

Improved therapeutic index for AP-5280 in vitro and in vivo as compared to carboplatin

March 5, 2004

Hudson Health Sciences licenses novel radiosensitizer IPdR

March 5, 2004

Chiron and Xoma collaborate to develop therapeutic antibodies for cancer

March 5, 2004

Novel CDK inhibitor with in vitro antiapoptotic activity described

March 4, 2004

ARH-460-16-2 set to enter clinic early next year

March 4, 2004

New protein kinase inhibitors for cancer and other disorders discovered at Janssen

March 4, 2004

MDM2 directly suppresses p21: broader anticancer activity for antisense MDM2 inhibitors

March 4, 2004

Satraplatin shows in vitro efficacy in tumor cells resistant to Taxotere and Taxol

March 3, 2004

Preclinical data supports use of INGN-241 regimens for lung, breast cancer

March 3, 2004

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...